CMIIU
Columbus Circle Capital Corp II UnitNASDAQFINANCIAL SERVICESSHELL COMPANIES
Key Statistics
Market Cap
$422.97M
P/E Ratio
—
EPS
—
Beta
—
52W High
$0.00
52W Low
$0.00
50-Day MA
$11.53
200-Day MA
$12.70
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Columbus Circle Capital Corp II Unit
Columbus Circle Capital Corp II Unit (CMIIU) is a specialized acquisition vehicle focused on the life sciences sector, specifically targeting innovative biotechnology, pharmaceuticals, and healthcare companies poised for growth through strategic mergers and acquisitions. Led by a highly experienced management team with deep industry expertise, CMIIU is committed to fostering advancement in key areas such as therapeutics and diagnostics. The company is strategically positioned to capitalize on emerging healthcare trends, leveraging its resources to identify and partner with transformative enterprises that align with its commitment to sustainable innovation and shareholder value creation.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | 0.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.14 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | $27.47M |
| % Insiders | 0.00% |
| % Institutions | 64.12% |
More FINANCIAL SERVICES Stocks
Data last updated: 5/5/2026